Clinical Trials Browser

Interventional × Carcinoma, Small Cell × GSK2879552 × Clear all

NCT02034123 2019-12-06

Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma

Phase 1 Terminated

29 enrolled 34 charts

Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma